Maynard Um
-
-
-
-
-
-
-
Cullinan Oncology, Inc. (CGEM) Tops Q1 EPS by 8c
-
-
-
-
-
-
-
Guggenheim Starts Cullinan Oncology Inc. (CGEM) at Buy
-
-
-
-
-
-
-
Cullinan Therapeutics (CGEM) spreader of 5K contracts of December 9 and 15 calls
-
-
-
-
-
-
-
Cullinan Oncology, Inc. (CGEM) Misses Q2 EPS by 25c
-
-
-
-
-
-
-
Cullinan Oncology, Inc. (CGEM) Tops Q4 EPS by 6c
-
-
-
-
-
-
-
Cullinan Therapeutics (CGEM) Receives U.S. FDA Clearance of Investigational New Drug Application for CLN-978
-
-
-
-
-
-
-
Cullinan Oncology Inc. (CGEM) PT Lowered to $38 at Morgan Stanley
-
431,655 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

